Cargando…
Mesenchymal stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects
Autores principales: | Chen, Xian, Shan, Yuheng, Wen, Yingyu, Sun, Jia, Du, Haike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227593/ https://www.ncbi.nlm.nih.gov/pubmed/32422152 http://dx.doi.org/10.1016/j.jinf.2020.05.020 |
Ejemplares similares
-
The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021) -
Comment on “Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain”
por: Kriek, R.
Publicado: (2014) -
The safety and short‐term outcomes of allogeneic hematopoietic stem cell transplantation with donor vaccination for COVID‐19
por: Ding, Yihan, et al.
Publicado: (2022) -
Short-term efficacy of unibody single-branched stent in the treatment of lesions involving the left subclavian artery: two-year follow-up outcomes
por: Chen, Bai-Lang, et al.
Publicado: (2020) -
Short-term efficacy of abatacept in the treatment of refractory ocular and cutaneous Behçet’s disease
por: Maciel, Marcus de Luca, et al.
Publicado: (2017)